By Jean-Pierre Despres, Vincenzo Di Marzo
This across the world well known writer crew offers a different and thorough research and distillation of the endocannabinoid process and its dating to stomach weight problems, diabetes, and heart problems. The endocannabinoid method (ECS) performs a massive position in cardiometabolic danger, in addition to modulating power stability, feeding habit, hepatic lipogenesis, and maybe glucose homeostasis. proof means that the ECS is overactive in human weight problems and dyslipidemia. severe to the administration of cardiometabolic danger, this new, well timed publication presents sensible overviews and administration assistance on many vital issues, together with: belly weight problems and the metabolic syndrome the endocannabinoid method and effort stability: capabilities and dysfunctions belly weight problems, the EC method, and cardiometabolic hazard
Read Online or Download Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk PDF
Best endocrinology & metabolism books
Drawing upon a wealthy choice of visible fabric, this ground-breaking ebook illustrates the complete diversity of lipid issues and explores the various different types of either basic and secondary dyslipoproteinemias. via bearing on the masses of top quality photos incorporated during this paintings, physicians may be capable of optimistically determine and diagnose the complete variety of lipid problems.
Articular cartilage is a distinct and hugely really good avascular connective tissue during which the supply of oxygen and glucose is considerably less than synovial fluid and plasma. Glucose is a necessary resource of power in the course of embryonic development and fetal improvement and is key for mesenchymal cellphone differentiation, chondrogenesis and skeletal morphogenesis.
The superiority of weight problems has now reached such proportions that during many components of the realm it really is the most dominant illnesses. weight problems results in a couple of critical ailments similar to kind 2 diabetes, heart problems, high blood pressure, stroke and melanoma in addition to mental difficulties and a terrible caliber of existence.
Endocrine Disruptors 2011 is a day symposium organised by way of iSmithers, and sister businesses Springborn Smithers and Smithers Viscient, aimed toward addressing key subject matters regarding the assessment of difficult results at the endocrine process and corresponding regulatory standards. The convention will assemble specialists from academia, govt, and from around the world to target present and destiny tendencies in checking out, interpretation and assessment of attempt effects and the way this pertains to or impacts regulatory actions.
- Effects of Extracellular Adenosine and ATP on Cardiomyocytes
- Genomics in Endocrinology: DNA Microarray Analysis in Endocrine Health and Disease (Contemporary Endocrinology)
- Pediatric and Adolescent Oncofertility: Best Practices and Emerging Technologies
- Atlas of Spleen Pathology
Additional info for Abdominal Obesity and the Endocannabinoid System: From Basic Aspects to Clinical Management of Related Cardiometabolic Risk
Brinton EA, Terry JG. Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women. Circulation 1996; 94(suppl):I-266. 13. Dallinga-Thie GM, Dullaart RPF, van Tol A. Concerted actions of cholesteryl ester transfer protein and phospholipid transfer protein in type 2 diabetes: Effects of apolipoproteins. Curr Opin Lipidol 2007; 18:251–257. 14. Dullaart RPF, de Vries R, Dallinga-Thie GM, et al. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003; 52(1):172–179. 2. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006; 444(12):875–880. 3. Kotronen A, Yki-J¨arvinen H. Fatty liver: A novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2007; 27:2276–2283. 4. Hiukka A, Fruchart-Najib J, Leinonen E, et al.
Hypertension 1995; 26:789–795. 22. Natali A, Taddei S, Quinones Ga, et al. Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension. Circulation 1997; 96:849–855. 23. Baron Ad, Brechtel-Hook G, Johnson A, et al. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 1993; 21:129–135. 24. Hulthen Ul, Endre T, Mattiasson I, et al. Insulin and forearm vasodilation in hypertension-prone men. Hypertension 1995; 25:214–218.